University of Notre Dame

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Brii, Qpex Partner To Bring

IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to

IN VITRO DIAGNOSTICS Arch Biopartners Inc. University of Alberta Arch Biopartners gets option to University of Alberta 's IBS diagnostic technology Public Canadian biotech Arch Biopartners In

Eli Lilly & Co. , which like many big pharmas faces patent expiries and an uncertain late-stage pipeline, has worked to improve ties with the venture and academic communities to help spur access to e